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1. Introduction 
The process of angiogenesis is essential for tumor progression and metastasis. New 
pathways have been identified to play a critical role in promoting and regulating blood 
vessel formation both in embryogenesis and in pathophysiological conditions. These 
pathways provide potential molecular targets for anti-angiogenic therapies to treat cancer 
and other vascular diseases. The critical cellular targets of these therapies are vascular 
endothelial cells (ECs) and supporting mural cells or pericytes (MCs) that are recruited from 
surrounding healthy tissue to form new vessels in the growing tumor. A challenging task 
has always been to visualize these biological processes in vivo as well as to screen for drugs 
affecting these pathological pathways. In this context, the zebrafish model represents an 
emerging vertebrate system to study the tumor angiogenesis process and to better 
understand the modification of tumor microenvironment by anti-angiogenesis therapy. Can 
a small tropical fish help to better understand the tumor angiogenesis process and identify 
new therapies for tumor angiogenesis ? In this chapter we illustrate how the zebrafish has 
emerged as a novel in vivo cancer model to study tumor-induced neovascularization and 
metastases. In the transparent zebrafish embryos, invasion and migration of tumor cells, 
their circulation in the vascular system, as well as the formation tumor-induced 
neovascularization can all be followed with high resolution in real time. Importantly, these 
zebrafish models allow to quantitate both metastatic behavior of transplanted tumor cells 
and tumor-cell induced neovascularization. The zebrafish model has the advantage of being 
a vertebrate equipped with easy and powerful genetic and imaging tools to investigate the 
mechanisms of tumor development and progression. In particular the transparency of 
embryos and lately also adult are transforming this model system in the leading in vivo 
model for cancer biology and tumor angiogenesis.  
2. The zebrafish model  
The zebrafish (Danio rerio) system has emerged in the past years as an ideal vertebrate 
model organism in which to study a wide variety of biological processes (Thisse and Zon, 
2002). Zebrafish is a small, freshwater teleost native of Ganges river in South-East India. 
Some of the advantages of the zebrafish animal model system, together with its small size 
and low cost, include fecundity, with each female capable of laying 200-300 eggs per week, 
external fertilization that permits manipulation of embryos ex utero, and rapid development 
of optically clear embryos, which allows the direct observation of developing internal 
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organs and tissues in vivo (Thisse and Zon, 2002). These attributes have led to the 
emergence of the zebrafish as a preeminent embryological model. The zebrafish has proven 
to be a powerful vertebrate model system for the genetic analysis of developmental 
pathways and has just started to be exploited as a model for human disease and clinical 
research (Lieschke and Currie, 2007; Skromne and Prince, 2008). If in the past 20 years 
zebrafish has served as an excellent model for understanding normal development using its 
powerful genetics and embryology, now is becoming a unique opportunity to uncover novel 
insights into the molecular genetics of human diseases. 
2.1 Zebrafish and angiogenesis 
The zebrafish system possesses many advantages for vascular studies. By 24 h after 
fertilization the zebrafish embryo has already developed a functional cardiovascular system 
(beating heart, aorta, cardinal vein and blood). Since the zebrafish embryo is relatively small 
and aquatic, zebrafish embryos are not completely dependent on a functional vascular 
system to continue to survive and develop. This happens because embryos receive enough 
oxygen by passive diffusion, thereby allowing a detailed analysis of animals with severe 
vascular defects (Stainier, 2001). Embryos without cardiac contraction or blood thus develop 
normally until their size outstrips diffusive oxygenation. This allows the consequences of 
genetic manipulation on cardiovascular development to be observed for longer than would 
be possible in mammals, in which abnormal heart or vascular development is fatal very 
early in development. By contrast avian and mammalian embryos die rapidly in the absence 
of a functional cardiovascular system and are not easy visualized internally without fixation 
and staining. 
Until 5 days post fertilization, the embryos are nearly transparent, allowing in vivo 
visualization of any tissue without instrumentation or manipulation other than microscopy. 
This feature allows observation of the heart and blood vessels during development even at 
single cell resolution. The availability of the fertilized egg for injection with genetic 
constructs greatly facilitates the generation of tissue-specific transgenics (Kawakami, 2007). 
Such transgenesis usually uses a native tissue-specific promoter to drive expression of a 
fluorescent reporter protein, such as green fluorescent protein (GFP). Examples of 
cardiovascular transgenic lines include Fli1:GFP (expresses GFP in endothelial cells and 
some neural crest-derived cells) (Lawson and Weinstein, 2002), kdrl:GFP (expresses GFP 
localized to endothelial cell) (Jin et al., 2005), GATA1:dsRED (expresses dsRED in 
erythrocytes) (Traver et al., 2003), CD41:GFP (expresses GFP in thrombocytes) (Lin et al., 
2005) and cmlc2:GFP (expresses GFP in cardiomyocytes) (Burns et al., 2005) and TGNL-
Cherry (expresses cherry in smooth muscle cells)(Gays and Santoro, personal 
communication).  
Coupled with the embryo’s optical clarity, these transgenic lines allow observation of in 
vivo cellular behavior in a manner impossible in other models. The striking transparency of 
the embryos facilitates morphological observation of internal organs in vivo under a simple 
stereomicroscope, and at the single-cell level using confocal and single plan microscopy. 
Transparent zebrafish embryos are also well suited for in vivo time-lapse imaging. The fast 
acquisition speed of spinning disk and 2-photon confocal microscopy reduces the recording 
times significantly when millimeter-sized embryos need to be imaged at high resolution and 
at short time intervals. Light Sheet Fluorescence Microscopy could also be very useful in 
zebrafish (Keller et al., 2008). These attributes, that have led to the emergence of the 
zebrafish as a preeminent embryological model, including its capacity for gain- and loss-  
www.intechopen.com
 
Modeling Tumor Angiogenesis in Zebrafish 
 
169 
 
Fig. 1. Representative images of 30hpf transgenic Tg(kdrl:GFPs843,gata1:deRedsd2 ) zebrafish 
embryos. Green fluorescent blood vessels and red fluorescent erythrocytes and 
macrophages are evident in all embryo. Arrow indicates point of tumor cells injections. 
of-function studies, provides a unique opportunity to uncover novel insights into the 
molecular genetics of development and diseases. The zebrafish system also offers the 
opportunity to carry out forward genetic analysis to identify as yet unidentified loci/genes 
affecting vascular development (Patton and Zon, 2001). Different techniques exist to 
generate point mutations, deletions and mutagenic insertions, which can be bred to 
homozygosis in order to determine their phenotypic consequences. Zebrafish also allows the 
powerful combination of loss-of-function and gain-of-function analyses (Zon and Peterson, 
2005). Altogether these data suggest the zebrafish system as an optimal model to study 
angiogenesis not only during development but also in pathological conditions such as 
tumor angiogenesis. 
2.2 Zebrafish and cancer 
The zebrafish (Danio rerio) has proven to be a powerful vertebrate model system for the 
genetic analysis of developmental pathways and is only beginning to be exploited as a 
model for human disease and clinical research. More recently, research with zebrafish has 
extended to model human diseases and to analyze the formation and functions of cell 
populations within organs (Dooley and Zon, 2000). This work has generated new human 
disease models and has begun to establish therapeutic possibilities, including genes that 
modify disease states and chemicals that rescue organs from disease. Zebrafish has recently 
entered the stage as a promising model system to study human cancer. This is largely due to 
the development of zebrafish transgenic lines expressing oncogenes and their amenability to 
genetic and pharmacological testing. Cancer progression in these animals recapitulates 
many aspects of human disease and opens the door for studies to identify genetic and 
chemical modifiers of cancer. The zebrafish is amenable to transgenic and genetic strategies 
that can be used to identify or generate zebrafish models of different types of cancer and 
may also present significant advantages for the discovery of tumor suppressor genes that 
promote tumorigenesis when inactivated by mutations (Amatruda et al., 2002). Importantly,  
www.intechopen.com
 
Tumor Angiogenesis 
 
170 
the transparency and accessibility of the zebrafish embryo and adult allows the 
unprecedented direct analysis of pathologic processes in vivo, in particular tumor 
angiogenesis (Moshal et al., 2010; Nicoli and Presta, 2007; Stoletov and Klemke, 2008). The 
attention has been further fueled by the development of xenograft models that allow the 
propagation and visualization of human cancer cells engrafted in optically transparent. The 
integration of zebrafish genetics with the large tool chest of reagents available to study 
human cancer cells provides a powerful new vertebrate model to visualize and dissect the 
mechanisms that drive cancer formation, angiogenesis and metastasis. Finally, zebrafish 
have many attributes that cancer researchers find attractive. Compared to mice, zebrafish 
require minimal care and are cost effective to maintain in the laboratory. A pair of adult fish 
produces several hundred fertilized eggs a week. The embryos develop externally and are 
transparent up to 1 month of age. Adult, casper mutant (noy-/-; nacre-/-) animals are also 
available that remain transparent throughout life and are amenable to in vivo 
transplantation studies (White et al., 2008). The remarkable transparency of zebrafish tissues 
allows direct imaging of cancer progression including cell invasion, intravasation, 
extravasation and angiogenesis (Rouhi et al., 2010b; Stoletov et al., 2007). 
Ultimately, high-throughput modifier screens based on zebrafish cancer models can lead to 
the identification of chemicals or genes involved in the suppression or prevention of the 
malignant phenotype (Lieschke and Currie, 2007). The identification of small molecules or 
gene products through such screens will serve as ideal entry points for novel drug 
development for cancer treatment. Here we focus on the current technology that takes 
advantage of the zebrafish model system to advance our understanding of the genetic basis 
of tumor angiogenesis and its treatment. 
2.3 Molecular mechanisms involved in angiogenesis 
The vascular system is the first organ to form and function during embryogenesis. Vascular 
development begins with the organization of endothelial cells (ECs) into a primitive 
vascular plexus that becomes progressively remodeled to ultimately form a complex 
vascular network, a process called angiogenesis (Carmeliet, 2003; Cleaver and Melton, 2003; 
Red-Horse et al., 2007). Afterwards, the developing vessels differentiate and mature by 
generating extracellular matrices, by expressing specific cell-cell molecules, and by 
recruiting mural cells (MCs)(pericytes and vascular smooth muscle cells) in a process called 
vascular maturation. MCs are recruited to the endothelial vasculature and sheathe it, 
providing support and contractility to the mature vascular system (Bergers and Song, 2005; 
Carmeliet, 2005). Formation and stabilization of the vascular system is essential for proper 
development of vertebrate embryos, as well as for the survival of adults. Mature vessels 
continue to provide metabolic homeostasis by supplying oxygen and nutrients and 
removing metabolic wastes. Several molecular mechanisms are involved during the 
vascular maturation process, including signaling pathways (e.g. PDGF, Angiopoietins, 
TGFb1, DlGF, S1P-EDG1), cell-cell and cell-matrix interactions (e.g. cadherins, connexins, 
integrins, MMPs, PAI1). Formation of new blood vessels is desirable for regenerative 
purposes, such as during tissue healing or transplantation, but can be pathological, as in 
diabetic retinopathy and cancer.  
Several studies in zebrafish have identified new mechanism involved in angiogenesis. It has 
been demonstrated that numerous angiogenic factors not only induce angiogenesis but also 
function as EC survival factors. Using genetic studies in zebrafish, we previously discovered 
that Birc2/cIap1, an inhibitor of apoptosis (IAP), is critical for the survival of endothelial 
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cells, which line the inner portion of blood vessels (Santoro et al., 2007). Apart from the 
relevance of these findings for improving understanding of vascular development, they may 
create new opportunities for further development of anti- angiogenic drug therapies. In fact, 
several reports demonstrate that IAP antagonist potentiate apoptosis in cancer cells by 
promoting induction of auto-ubiquitination and degradation of cIAPs, which culminates in 
TNFα-mediated cell death suggesting an important role of this pathway in tumor 
angiogenesis (Wu et al., 2005).  
Non-coding RNAs called microRNAs also modulate the response of the vascular 
endothelium to angiogenic stimuli. Recently different microRNA (e.g. miRNA126, and 
miRNA296 have been found to be associated with angiogenesis in zebrafish (Fish and 
Srivastava, 2009). However, many other mechanisms remain to be discovered.  
2.4 Tumor angiogenesis 
A tumor consists of a population of rapidly dividing and growing cancer cells. Cancer cells 
have lost their ability to divide in a controlled fashion as a consequence tumor cells rapidly 
accumulate mutations that allow cancer cells (or sub-populations of cancer cells within a 
tumor) to grow more (Carmeliet, 2003; Folkman, 2007). Tumors cannot grow beyond a 
certain size, generally 1–2 mm3 due to a lack of oxygen and other essential nutrients. Tumors 
cells have then have acquired a specific feature that is to induce blood vessel growth (a 
process called tumor angiogenesis) by secreting various endothelial growth factors. 
Endothelial specific growth factors such as bFGF and VEGF-A can induce capillary growth 
into the tumor that in turn allow tumor expansion. Tumor angiogenesis is a necessary and 
required step for transition from a small harmless cluster of cells to a large tumor. 
Angiogenesis is also required for the spread of a tumor, or metastasis. Single cancer cells can 
break away from an established solid tumor, enter the blood vessel, and be carried to a 
distant site, where they can implant and begin the growth of a secondary tumor. Evidence 
now suggests the blood vessel in a given solid tumor may, in fact, be mosaic vessels, 
composed of endothelial cells, mural cells and neoplastic cells. The subsequent growth of 
such metastases will also require a supply of nutrients and oxygen and a waste disposal 
pathway. 
Endothelial cells have long been considered genetically more stable than cancer cells. This 
genomic stability confers an advantage to targeting endothelial cells using antiangiogenic 
therapy, compared to chemotherapy directed at cancer cells, which rapidly mutate and 
acquire 'drug resistance' to treatment. For this reason, endothelial cells are thought to be an 
ideal target for therapies directed against them (Folkman, 2007). Tumor blood vessels have 
perivascular detachment, vessel dilation, and irregular shape. It is believed that tumor blood 
vessels are not smooth like normal tissues, and are not ordered sufficiently to give oxygen to 
all of the tissues. Endothelial precursor cells are organized from bone marrow, which are 
then integrated into the growing blood vessels. Afterwards endothelial cells differentiate 
and migrate into perivascular space, providing nutrients that allow neoplastic cells to 
growth the tumor mass. In this process VEGF-A plays a crucial role since it is important for 
denovo formation of new blood vessels at sites of tumor formation allowing cancer cell to 
growth (Bergers and Hanahan, 2008). 
Tumor angiogenesis is one of the most prominent mechanisms driving tumor development 
and progression. Tumor angiogenesis research is a cutting-edge field in cancer research and 
recent evidence also suggests traditional therapies, such as radiation therapy, may actually 
work in part by targeting the genomic stable endothelial cell compartment, rather than the 
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genomic unstable tumor cell compartment. New blood vessel formation is a relatively 
fragile process, subject to disruptive interference at several levels. In short, the therapy is the 
selection agent that is being used to kill a cell compartment. Tumor cells evolve resistance 
rapidly due to rapid generation time (days) and genomic instability (variation), whereas 
endothelial cells are a good target because of a long generation time (months) and genomic 
stability (low variation). As a consequence crucial targets for therapeutic intervention have 
been identified and validated. Based on these efforts and achievements, targeted drug 
development programs have been implemented to interfere with tumor angiogenesis as an 
attractive strategy in cancer treatment. As a promising result the first targeted anti-
angiogenic drugs have been approved for a variety of solid metastasizing cancers. The first 
generation of these molecules targets the two most prominent regulatory components of 
tumor angiogenesis: the vascular endothelial growth factor (VEGF-A), produced by tumor 
cells, and the VEGF-A receptor tyrosine kinase, which is expressed on vascular endothelial 
cells. Beyond the VEGF receptor system, additional tumor-angiogenic systems are presented 
as new potential targets for anti-angiogenic therapy (Bergers and Benjamin, 2003). 
Over the last decades studies of tumor angiogenesis have concentrated mainly on the 
endothelial cells component, while the interest for mural cells has lagged behind (Bergers 
and Hanahan, 2008). Mural cells (MCs)(aka pericytes or vascular smooth muscle cells) are 
perivascular cells that wrap around blood capillaries. They communicate with endothelial 
cells by direct physical contact through a jointly synthesized basement membrane and 
reciprocal paracrine signalling. MCs and endothelial cells are thereby interdependent and, 
as such, defects in either endothelial cells or pericytes can affect the vascular system. Mural 
cells have various demonstrable functions in different physiological contexts, including 
stabilization and homeostatic regulation of mature blood vessels; facilitation of vessel 
maturation in the context of neovascularization; provision by their intimate association of 
endothelial cell survival signals; and limitation of cell transit across the vascular wall. The 
functional significance of mural cells in development is underscored by genetic depletion or 
disruption of mural cells association with the developing vasculature, which results in blood 
vessel dilation, widespread microvascular leakage and subsequent lethality during late 
gestation (Bergers and Song, 2005; Conway et al., 2001; Red-Horse et al., 2007). In tumors, 
MCs are typically less abundant and more loosely attached to blood vessels than in normal 
tissues, but their association is still important, as shown in a growing body of experimental 
evidence which indicates that pericytes help to maintain the integrity and functionality of 
the tumor vasculature (Armulik et al., 2005; Majesky, 2007). Interestingly, a growing body of 
evidence indicates that MCs, the periendothelial support cells of the microvasculature, are 
also important cell constituents of the aberrant tumor vasculature. When therapies impair 
neovascularization and/or elicit vascular regression, some tumors evidently rely on 
pericytes to help keep a core of pre-existing blood vessels alive and functional. This concept 
has evolved from the observation by several groups that, although inhibition of VEGF 
signalling can lead to substantial reduction in tumor vascularization, distinctive functional 
vessels remain that are slim and tightly covered with pericytes. These observations suggest 
that endothelial cells can induce MCs recruitment to protect themselves from death 
consequent to the lack of the crucial tumor-derived survival signals conveyed by VEGF-A. 
This hypothesis is supported by the findings that tumor vessels lacking adequate MCs 
coverage are more vulnerable to VEGF-A inhibition and that tumor MCs, which are 
juxtacrine to endothelial cells, express appreciable levels of VEGF-A and potentially other 
factors that support endothelial cell survival. The understanding of these mechanisms  
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represents an important first step to elucidate pathways leading to many vascular-
associated disorders, including tumor angiogenesis. The integration of zebrafish transgenic 
technology with human cancer biology may aid in the development of cancer models that 
target specific organs, tissues, or cell types within the tumors. Zebrafish could also provide a 
cost-effective means for the rapid development of therapeutic agents directed at blocking 
human cancer progression and tumor-induced angiogenesis (Amatruda et al., 2002). 
2.5 Zebrafish as a model to study tumor angiogenesis 
It has already been shown that blood vessels can grow by positional cues as well as secreted 
factors from other tissues. During pathological states, solid tumors use molecular 
mechanisms that are involved during normal angiogenesis to promote the disease state and 
establish a microenvironment to render normally quiescent endothelial cells to proliferate. 
In this respect, tumor tissue secretes angiogenic factors that can regulate blood vessel 
development (Bergers and Benjamin, 2003). However, not much is known about the cellular 
signals that initiate or establish cross talk between the tumor and the stromal cells. The 
study of the cellular interaction of tumor cells with its surrounding endothelial cells is 
expected to aid in the discovery of genes/pathways involved in the process of blood vessel 
formation in vivo. The microenvironment of a host-tumor interface has a profound influence 
on disease progression and has the potential for cancer therapy. Despite the importance of 
tumor-stromal interactions, there is a limited understanding of signaling cross talk between 
the tumor and the host microenvironment. Much of the information regarding the signaling 
networks comes from cell culture studies; however, the main drawback of this approach is 
the difficulty in extrapolating these findings to the whole organism. Thus, there is a need to 
develop suitable whole animal models to study the host- tumor interface.  
In this respect, the zebrafish xenotransplantation system represents a novel model for 
defining tumor angiogenesis by the means of high-throughput manipulation of host 
environment, via morpholino knockdown of genetic pathways and treatment with small 
molecule inhibitors (Haldi et al., 2006; Nicoli et al., 2007; Rouhi et al., 2010a; Stoletov et al., 
2007). Although embryonic and tumor vasculatures have morphological differences, they 
are mechanistically similar in the process of angiogenesis; therefore, studying the zebrafish 
xeno-transplantation model will allow us to better understand the impact of manipulation 
of the host microenvironment on tumor angiogenesis. 
2.6 The xenotranplant experiments 
The xenotransplantation studies conducted in mice and humans are limited by difficulties 
for direct observation in real time of cellular and signaling events in the context of the whole 
organism. Therefore, the future challenge will be to analyze the functional role of signaling 
interaction in modulating tumor angiogenesis by the host environment and determining its 
relationship with the inflammatory response and tumor cell metastasis using zebrafish as a 
transparent and tractable whole animal model system. In this regard, the use of transparent 
adult zebrafish casper mutant with fluorescently tagged blood vessels and myeloid-specific 
transgenic zebrafish will be advantageous to study cellular responses in real time (White et 
al., 2008). The other advantages include the speed of analysis for tumor angiogenesis (24-48 
hours) and the ability to perform whole- mount in situ gene expression analyses in 
heterologous tumor cells vs the tumor-induced gene expression in the surrounding host 
environment leading to the attractiveness and appropriateness of the zebrafish model to 
study tumor angiogenesis. Various groups have shown that human cancer cells when  
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grafted in early zebrafish embryos (1/2-day-old) may promote neoangiogenesis from 
embryos vessels and spread of metastasis in all embryos, thereby validating the 
xenotransplantation procedure to study tumor angiogenic and metastatic processes in 
zebrafish (Haldi et al., 2006; Nicoli et al., 2007; Stoletov et al., 2007) (Topczewska et al., 2006; 
Marques et al., 2009). The major advantage of the xenotransplantation in early embryos is 
the immature immune system that permits cancer cell engraftment without rejection. The 
studies by Haldi and collaborators demonstrated the feasibility of using 2 days 
postfertilization (dpf) zebrafish for xeno-transplantation where the fluorescently labeled 
human carcinoma was grafted into the yolk sac and observed until 7 days postinjection for 
cancer cell proliferation, migration, infiltration of tumor masses by endothelial cells, vessel 
remodeling, and stimulation of angiogenesis (Haldi et al., 2006). This technique represents a 
promising vertebrate model to study tumor-host microenvironment and to screen for 
antiangiogenic compounds. Later on, Presta and collaborators have refined the 
xenotransplantation process by transplanting tumor cells directly into the perivitelline space 
between the periderm and the yolk syncytial layer of the zebrafish embryos at 48 hours 
postfertilization and observed the neoangiogenic response originating from the subintestinal 
vessel plexus (Nicoli et al., 2007). Using the early zebrafish xenotransplantation model, Cao 
and collaborators monitored the dissemination of single-tumor cells from the primary sites 
and recapitulated early stages of clinical metastasis (Rouhi et al., 2010b). They concluded 
that hypoxia and VEGF-A-induced neovascularization promoted tumor invasion and 
metastasis by increasing dissemination of tumor cells into the circulation. Using the 
zebrafish xenotransplantation, Vlecken and Bagowski documented the significance of LIM 
domain kinases 1 and 2 signal molecules in tumor metastasis and angiogenesis of human 
pancreatic cancer cell lines and suggested that simultaneous targeting of both LIM domain 
kinases could inhibit tumor progression and metastasis (Vlecken and Bagowski, 2009). 
Hence, zebrafish early xenotransplantation may represent a powerful tool to understand 
how the angiogenic phenotype of the cancer culminates in metastatic spread of tumor and 
will be beneficial to study the molecular mechanism of antiangiogenesis therapy. 
Later on, Stoletov and colleques successfully transplanted human cancer cells in a 30-day-
old transparent zebrafish and studied the dynamics of microtumor formation and 
angiogenesis, thereby making this an excellent model appropriate to study the basics of 
vessel remodeling and alteration in subcellular compartments during tumorigenesis 
(Stoletov et al., 2007). It is not fully understood whether the new vessels triggered by human 
cancer cells are the result of redirection of the preexisting vessels and/or recruiting from the 
circulating endothelial cells. Therefore, using this late zebrafish xenotransplantation model 
will be better suited to investigate the origin of these endothelial cells in the transparent 
zebrafish host in which the vasculature has already established. The other advantages of 
using late xenotransplantation include easy interpretation of tumor-induced vascular 
effects, since the major organs in the juvenile fish including the vasculature have fully 
formed including smooth muscle cells and pericytes that can play a key role in tumor 
angiogenesis and it eliminates the concern related to the developmental defects due to 
embryologic manipulation. On the other hand, a limitation for this late model is the 
requirement of chemical suppression of the host immune function for successful grafting of 
the cancer cells. Recently, the generation of homozygous diploid clonal zebrafish lines by 
heat shock method made it possible to perform transplantation of hepatic tumor from one 
fish to another without rejection of the graft and without compromised by 
immunosuppression or sublethal γ-irradiation (Mizgireuv and Revskoy, 2006). However, 
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clonal zebrafish model is suitable for studying various cancer types of zebrafish origin; it 
cannot be used as a host for transplanting human cancer cells without immunosuppression. 
To date, the early events that trigger vascular remodeling and tumor angiogenesis during 
tumor formation are not known. In addition, micrometastasis is a major cause of deaths in 
cancer patients. In this regard, a 30-day-old zebrafish xenotransplantation might also 
represent an adequate model to dissect the molecular and cellular mechanisms leading to 
micro-tumor formation. 
2.7 Tumor angiogenesis-associated molecular mechanisms in zebrafish 
Novel function of important genes associated with the process of tumor angiogenesis has 
been identified recently using the zebrafish model, including galectin-1 (Thijssen et al., 
2006), Chemokine receptor 7 (Miao et al., 2007), LIM domain kinase 1 and 2 (Vlecken and 
Bagowski, 2009), angiomodulin (Hooper et al., 2009), Hypoxia inducible factor (Lee et al., 
2009). In the past we identified a new molecule, Birc2/cIAP, important for endothelial 
survival in normal and pathological conditions (Gyrd-Hansen et al., 2008; Santoro et al., 
2007). This study has implications for future design of antiangiogenic therapy. Available 
antiangiogenic agents (all VEGF inhibitors) induce endothelial cell apoptosis in existing 
vessels. Hence, additional antiangiogenic agents with complementary mechanisms are 
required. Because Birc2 has enzymatic activity, it might become an attractive target for 
drug development. We are currently testing a specific cIAP antogonists (BV6 and 
derivates) in endothelial cells in zebrafish (Varfolomeev et al., 2007). These small 
molecules potentiate apoptosis in cancer cells by promoting caspases activation. We will 
test these compounds and its derivates on out xenograft model of tumor angiogenesis in 
zebrafish. During the last years we also worked on characterization of mural cells 
(pericytes and vascular smooth muscle cells) (Santoro et al., 2009). Identify the molecular 
mechanisms involved in mural cell differentiation is very important to target tumor 
angiogenesis because it is known that tumor endothelial cells required pericytes/mural 
cells to survive (von Tell et al., 2006). Better understanding of the molecular genetic of 
mural cells may lead to the identification of new important targets for tumor angiogenesis 
and help to design anti-angiogenic drugs. 
Nicoli et al., showed that morpholino knockdown of VE-cadherin expression selectively 
prevented tumor cell-induced angiogenesis by FGF2, but not normal vessel development 
including formation of the intersegmental and subintestinal vessels (Nicoli et al., 2007). 
These findings are surprising in light of the fact that VE-cadherin null mice display several 
vascular defects in vessel assembly that cause embryonic lethality at day 9.5 (Carmeliet et 
al., 1999). The apparent discrepancy in these studies may be due to differences in the 
vascular programs utilized by fish and mammals. It is also possible that tumor-induced 
vessel formation in zebrafish may be uniquely sensitive to perturbation of VE-cadherin 
expression or that the same programs that drive tumor-induced angiogenesis are different 
from those that drive developmental vasculogenesis. 
Recently, Stoletov and Klemke demonstrate that highly invasive human cancer cell lines 
such as HT1080 or Hep3 are also invasive in zebrafish host while low invasive human cells 
as MDA-435 do not disseminate in the host zebrafish tissue (Stoletov and Klemke, 2008). 
Human cancer cells overexpressing RhoC or src display increased cell dissemination when 
transplanted in zebrafish demonstrating that the molecules (ECM, growth factors, MMPs) 
and mechanisms playing a role in cancer cell-host tissue interaction are highly conserved 
between human and zebrafish. 
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3. Conclusions 
Zebrafish recently entered the stage as a promising model system to study human cancer. 
This has been largely due to the development of transgenic and xenograft models of cancer, 
and their amenability to genetic and pharmacological testing. Cancer progression in these 
animals recapitulates many aspects of human disease and opens the door for studies to 
identify genetic and chemical modifiers of cancer. There are general advantages and 
limitations of using zebrafish as an in vivo model to study tumor angiogenesis. These 
include: 
Advantages 
 Zebrafish husbandry: inexpensive to obtain and maintain large number of adult and 
embryo zebrafish.  
 Generation of larvae with deletion or overexpression of specific genes can be easily 
accomplished using available tools (e.g. morpholinos, RNA, mimics).  
 Genetically manipulated zebrafish strains that are defective or have acquired functions 
of certain gene products are available (e.g. zinc-fingers, ENU, tilling).  
 Transgenic zebrafish lines that express reporter genes in particular cell types are also 
available in the scientific community.  
 Addition of active chemical stimulators or inhibitors to the water enables analysis of 
intervention of these compounds on physiological and pathological processes.  
 Turnover time for experiments is relatively short. 
 Optical clarity of zebrafish embryos allows visualization of vascular and hematopoietic 
cells as well as tumor cell dissemination in living animals. 
 Zebrafish embryos allows implantation of mammalian tumor cells, including human 
and mouse tumor cells, due to the absence of a functional immune system at this stage 
Limitations 
 Few antibodies against zebrafish proteins are available so far. For this reason it is 
difficult to perform immunofluorescence analyses in zebrafish samples. 
 Due relative small size of zebrafish larvae, you need skillful and careful trainees to 
perform experiments. 
 As most mammalian tumors grow at 37 °C, it is difficult to study the process of 
xenograft tumor growth at the optimal temperature. 
 Microinjection of tumor cells into the perivitelline space of a large number of zebrafish 
embryos is a tedious procedure and requires highly skillful micro-operations. 
These models are already being utilized by academia and industry to search for genetic and 
chemical modifiers of cancer with success. The attention has been further stimulated by the 
amenability of zebrafish to pharmacological testing and the superior imaging properties of 
fish tissues that allow visualization of cancer progression and angiogenesis in live animals. 
Here we have described how the zebrafish/tumor xenograft model is becoming an 
emerging vertebrate system to study tumor angiogenesis. In particular this model become 
very interesting to analyze the molecular and cellular mechanisms of tumor angiogenesis in 
real time. Within the past several years, zebrafish has shown great promise to become a 
powerful animal model to study cancer progression and several laboratories have focused 
on zebrafish and tumor biology. However, despite a significant progress, more work is 
required to fully explore how closely these processes in zebrafish may parallel mammalian 
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cancer mechanisms and how well they might be translated to human disease. This 
improvement will require more specific comparative studies among transgenic and 
xenograft zebrafish and mouse/mammalian models of cancer/tumor angiogenesis and their 
relevance to the disease. When all these studies and analyses will be performed the 
zebrafish model will have the full potential to be used and embraced by the cancer research 
community. 
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